NGN Optiscan Fund II, LP
NGN Capital · adviser of record: NGN Capital LLC · 2019 vintage
NGN Optiscan Fund II, LP is a 2019 venture fund managed by NGN Capital. It reported $1.8mm in gross assets at year-end 2019, its highest reported value.
- Latest value held
- $1.8mm year-end 2019
- Peak
- $1.8mm year-end 2019
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2019 | $1.8mm | – | – |
Other funds from NGN Capital
- NGN Optiscan Fund I, LP 2018
- NGN Biomed Opportunity Annex Fund LP 2013
- NGN Biomed 2A 2011
- NGN Biomed 1A 2011
- NGN Biomed 1B 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-6371452364. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.